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Summary This paper describes the epidemiology of AIDS-associated non-Hodgkin's lymphoma (NHL) in the
World Health Organization (WHO) European Region. Data, collected by the WHO Collaborating Centre on
AIDS in Paris, France, were derived from the national AIDS surveillance systems of 21 countries. Among
53,042 cases reported as of the end of June 1991, 1,617 (3.0%) had NHL as the presenting clinical
manifestation of AIDS. The proportion of cases presenting with NHL ranged from 1.1% in children infected
perinatally to 3.9% among haemophiliacs. In comparison with intravenous drug users (IVDUs) (2.6% of
whom had NHL), a moderate excess was found among homosexual or bisexual men (odds ratio - OR -:1.2,
95% confidence interval - CI -:1.0-1.3). Over time, the proportion of NHL was constant, but whereas among
homosexual or bisexual men the frequency of NHL as AIDS-indicator disease significantly increased (9.7%
per year), among IVDUs a significant downward trend emerged (17.1% per year). In respect to age, two peaks
of NHL were seen at the age groups 10-19 (3.8%) and 50-59 (4.3%). The proportion of AIDS-associated
NHL significantly increased with increasing age among homosexual and bisexual men and heterosexuals
whereas it decreased among IVDUs. All these differences, however, have to be interpreted cautiously on
account of the limitations of the reporting systems.
Non-Hodgkin's lymphoma (NHL) is a group of hetero-
geneous malignancies representing, in Western countries, less
than 2% of all neoplasms in the general population (Levi et
al., 1989; Jensen et al., 1990). In Europe, the highest
incidence rates for NHL were registered in Switzerland and
Northern Italy among males, and in Scotland and Switzer-
land among females. Eastern European countries showed
lower rates than Western countries (Levi et al., 1989).
It is known that the risk ofNHL is increased by congenital
or acquired immunologic defects (Kinlen, 1982; Penn, 1983).
Patients with genetically determined immunosuppression, as
well as patients iatrogenically immunosuppressed after organ
transplantation, have an incidence of NHL and of other
lymphoid neoplasias 30 to 50-fold higher than that observed
in the general population (Kinlen, 1982; Penn, 1983).
The incidence of NHL in the United States and in other
Western countries has been steadily rising since the early
1970s (Pickle et al., 1987), and in more recent years a
significant proportion of this increase is attributable to NHL
that arise in the setting of human immunodeficiency virus
(HIV) infection (Karp & Broder, 1991).
Acquired immunodeficiency syndrome (AIDS)-associated
NHL is characteristically a high-grade B-cell malignancy,
often multifocal, that frequently originates in extra-nodal
sites, in particular in the central nervous system (Ziegler et
al., 1984; Kaplan et al., 1989). Interestingly, Epstein Barr
virus (EBV) infection is consistently present in primary lym-
phomas of the central nervous system among AIDS patients
(MacMahon et al., 1991), and also many of the AIDS-
associated lymphomas classified as immunoblastic or Burkitt's
lymphomas appear to be EBV-driven lymphoproliferations
(Editorial, 1991).
As of June 1991, 53,042 AIDS cases, from 21 countries
belonging to the World Health Organization (WHO)
European Region, were reported to the WHO Collaborating
Centre on AIDS in Paris, France. These data were used in
order to describe the epidemiology of AIDS-associated NHL
in the different HIV transmission categories and geographic
areas, thus extending and updating a previous study on a
more limited number of cases in 15 European countries
(Casabona et al., 1991).
Material and methods
The 30th June 1991 update of the European Non Aggregate
AIDS Data Set was analysed (European Centre for the
Epidemiological Monitoring of AIDS, 1991). Such data set
contains information for each individual AIDS case recorded
by the national surveillance system of 21 countries (Table I).
The data are collected by the WHO Collaborating Centre on
AIDS in Paris, France, according to a standard core of
epidemiologic information, which includes country of report,
sex, age, year of AIDS diagnosis, HIV transmission category
and reported indicator disease at the time of AIDS diagnosis.
Disease indicators were classified according to the follow-
ing hierarchy: opportunistic infections; Kaposi's sarcoma
(KS); opportunistic infections plus KS; all NHL (i.e.,
immunoblastic lymphoma, Burkitt's lymphoma and primary
lymphoma of the brain); HIV encephalopathy; HIV wasting
syndrome and lymphoid interstitial pneumonia. Whereas
primary lymphoma of the brain and Burkitt's lymphoma
were included in the Center for Disease Control (CDC)
AIDS definition criteria since 1981, immunoblastic lym-
phoma has been a reportable condition only since 1985
(Centers for Disease Control, 1987). Cases showing more
than one disease indicator at the time of AIDS diagnosis
were assigned to the one which ranked first in the aforemen-
tioned classification.
Individuals were assigned to HIV transmission category
according to CDC defined criteria. The effects of age, sex,
year of AIDS diagnosis and HIV transmission category on
the frequency of AIDS-associated NHL were modelled by
use of unconditional multiple logistic regression equations,
fitted by the method of maximum likelihood (Baker &
Nelder, 1978; Breslow & Day, 1980). In the assessment of the
influence of age on the proportion of AIDS cases with NHL,
an interaction term for age and HIV transmission category
(i.e., homosexuals, bisexuals, heterosexuals versus drug users)
was included in the model. The significance of linear trends
was assessed by computing the difference between the
deviances of the model with and without the variable of
interest (Baker, 1985).
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Table I Distribution of AIDS cases by country of residence and
non-Hodgkin's lymphoma at presentation. WHO European Region,
1982- 1991
Country of Number of AIDS cases with
residence AIDS cases non-Hodgkin's lymphoma
No. No. (%) MLR-ORa
(95% CI)
Northern Europe:
Germany 6,604 241 (3.6)
Iceland 18 0 (0.0)
Netherlands 1,745 65 (3.7)
Norway 217 5 (2.3)
Sweden 587 26 (4.4)
United Kingdom 4,758 140 (2.9)
Total 13,929 477 (3.4) 1b
Central Europe:
Austria 594 32 (5.4)
Belgium 896 30 (3.3)
France 15,534 481 (3.1)
Monaco 6 0 (0.0)
Switzerland 1,891 47 (2.5)
Total 18,921 590 (3.1) 1.0
(0.9-1.1)
Southern Europe:
Israel 153 7 (4.6)
Italy 9,792 313 (3.2)
Portugal 676 17 (2.5)
Spain 9,112 202 (2.2)
Turkey 44 0 (0.0)
Total 19,777 539 (2.7) 0.9
(0.8- 1.0)
Eastern Europe:
Czechoslovakia 25 1 (4.0)
Hungary 59 3 (5.1)
Poland 70 0 (0.0)
USSR 50 0 (0.0)
Yugoslavia 211 7 (3.3)
Total 415 11 (2.7) 0.8
(0.4-1.4)
All countries 53,042 1,617 (3.0)
aMultiple logistic regression (MLR) odds ratio (OR) and 95%
confidence interval (CI), adjusted for age, sex, HIV transmission
category and year of AIDS diagnosis. bReference category.
Results
NHL as disease indicator at AIDS diagnosis was present in
1,617 out of the 53,042 cases (3.0%) from the WHO
European region, reported to the WHO-Collaborating Centre
on AIDS in Paris, France, as of the end of June 1991.
As shown in Table I, the percentage of AIDS cases presen-
ting with NHL ranged from 0.0% in Iceland, Monaco,
Poland, USSR and Turkey to 5.4% in Austria (Table I).
Overall, Eastern and Southern European countries showed a
lower percentage of NHL (2.7% in both areas) among their
AIDS cases than Central (3.1%) and Northern (3.4%) coun-
tries (Table I). In comparison with Northern Europe, and
after allowance for the effect of age, sex, HIV transmission
category and year of AIDS diagnosis, however, no significant
differences emerged (Table I).
Over time, AIDS-associated NHL in the WHO European
region increased very substantially in absolute terms in all
transmission categories (from 16 in 1984 to 398 in 1990)
(Figure 1). As a proportion of AIDS cases, NHL did not
show a significant change (2.9% up to 1985 verses 3.1% in
1990-91). An upward trend was, however, detected in
homosexual or bisexual men (9.7% per year; 95% confidence
interval CI: 4.7%; 14.9%). Conversely, a significant down-
ward trend in the percentage of AIDS cases presenting with
NHL emerged among intravenous drug users (IVDUs)
(- 17.1% per year; 95% CI: - 22.2%; - 11.6%) (Figure 2).
As concerns HIV transmission category, the frequency of
NHL ranged from 1.1% in children infected perinatally to
3.9% among haemophiliacs (Table II). Odds ratios (ORs) of
presenting NHL at AIDS diagnosis were computed taking
IVDUs as reference category. After allowance for the effect
of age, sex and year of AIDS diagnosis, an excess of border-
line statistical significance was found among homosexual or
bisexual men (OR= 1.2, 95% CI: 1.0-1.3). Conversely, a
marked lack of AIDS-associated NHL appeared among chil-
dren infected perinatally (OR = 0.4, 95% CI: 0.2-0.7) (Table
II).
Less than 1% of AIDS cases in the first year of life had
NHL. Such percentage peaked up to nearly 4% in the 10-19
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Figure 1 Number of AIDS cases with non-Hodgkin's lymphoma
(NHL) by year of AIDS diagnosis and transmission category.
Europe, 1982- 1991.
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Figure 2 Percent of AIDS cases with non-Hodgkin's lymphoma
(NHL) by year of AIDS diagnosis and transmission category.
WHO European Region, 1982 -1991.
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Table II Distribution of AIDS cases with non-Hodgkin's lymphoma
by transmission category. WHO European Region, 1982-1991'
Number of AIDS cases with
AIDS cases non-Hodgkin's lymphoma
No. No. (%) MLR-ORb
(95% CI)
Transmission
catetory
IVDUsC 17,695 467 (2.6) Id
Homosexual men 23,275 791 (3.4) 1.2
(1.0-1.3)
Homosexual men
and IVDUs 1,012 22 (2.2) 0.8
(0.5- 1.2)
Heterosexuals 4,487 116 (2.6) 1.0
(0.8- 1.2)
Haemophiliacs 1,422 55 (3.9) 1.3
(0.9- 1.7)
Blood transfusion
recipients 1,645 52 (3.2) 1.1
(0.8- 1.5)
Mother to child 885 10 (1.1) 0.4
(0.2-0.7)
aIt does not include 2,621 cases with unknown HIV transmission
category. bMultiple logistic regression (MLR) odds ratio (OR) and 95%
confidence interval (CI), adjusted for age, sex and year of AIDS
diagnosis. clntravenous drug users. dReference category.
age group, to decrease steadily thereafter until the age group
30-39. A second, more elevated peak (4.3%) was seen at age
50-59 (Figure 3). On account of small figures, the percen-
tages of AIDS cases with NHL in younger age groups had,
however, very wide 95% CIs (Figure 3).
The age pattern of NHL showed discrepancies across HIV
transmission categories. The percentage of AIDS cases pres-
enting with NHL tended to increase with increasing age
among homosexual or bisexual men and heterosexuals,
whereas a significant inverse trend was seen among IVDUs
(Table III). The heterogeneity of these two trends was
significant (x2I = 31.1 1; P< 0.001).
NHL was diagnosed slightly more frequently among
IVDU men (2.8%) than in IVDU women (2.1%) (OR for
women vs men = 0.7, 95% CI: 0.6-0.9). No difference, on
the other hand, emerged between the frequency of NHL in
heterosexual men (2.5%) and in heterosexual women (2.7%)
(Table III).
Discussion
The present paper is the largest report on a series of AIDS-
associated NHL outside the United States (Beral et al., 1991)
published so far. In agreement with data from the United
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Figure 3 Percent of AIDS cases with non-Hodgkin's lymphoma
(NHL) by age and 95% confidence intervals. WHO European
Region, 1982-1991. (In parenthesis, number of AIDS cases with
NHL).
Table III Distribution of AIDS cases with non-Hodgkin's lymphoma (NHL) by age,
1982- 1991.
Homosexual men
AIDS
cases:NHL
31:1
799:24
3,176:108
4,706:130
4,825:134
6,758:259
2,381:107
543:23
Transmission category
Intravenous drug users
(%) MLR-ORa AIDS (%) MLR-ORa
(95% CI) cases:NHL (95% CI)
(3.2)
(3.0) 1
(3.4)
(2.8)
(2.8)
(3.8)
(4.5)
(4.2)
IC
1.1
(0.7-1.7)
0.9
(0.6- 1.4)
0.9
(0.6- 1.4)
1.3
(0.8- 1.9)
1.5
(0.9-2.3)
1.4
(0.8-2.4)
113:3 (2.7)
IC
2,755:106 (3.9)
7,777:203 (2.6) 0.7
(0.6-0.9)
4,910:104 (2.1) 0.6
(0.5-0.8)
1,599:39 (2.4) 0.7
(0.5- 1.2)
416:11 (2.6)]
44:0 (0.0) - 0.7
(0.4- 1.2)
5:0 (0.0)
Heterosexuals
AIDS (%)
cases:NHL
33:0 (0.0)
382:10 (2.6) 1
952:20 (2.1)
971:14 (1.4)
650:20 (3.1)
826:25 (3.0)
450:18
213:7
(4.0)
(3.3)
13.1 1;p<0.001
23,275:791 (3.4)
8.00;p = 0.005
13,768:383 (2.8) IC
3,927:84 (2.1) 0.7
(0.6-0.9)
2,548:64 (2.5)
1,939:52 (2.7)
'Multiple logistic regression (MLR) odds ratio (OR) and 95% confidence interval (CI), allowing for age and sex (when appropriate), and
year of AIDS diagnosis. bThe sum does not add up to the total because of missing values. cReference category.
transmission category and sex. Europe,
Age (years):b
<20
20-24
25-29
30-34
35-39
40-49
50-59
> =60
MLR-ORa
(95% CI)
IC
0.9
(0.4- 1.9)
0.6
(0.3- 1.4)
1.4
(0.6-3.1)
1.4
(0.7-3.0)
1.9
(0.8-4.2)
1.3
(0.5-3.3)
x2, for trend
Sex:
Men
Women
9.70;p = 0.002
IC
1.2
(0.8- 1.8)k-.- . .-I
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States, where 2,824 out of 97,258 AIDS cases (2.9%) had
NHL (Beral et al., 1991), and with a similar study on AIDS-
associated NHL in 15 European countries, where 3.3% of
cases had NHL (Casabona et al., 1991), the results of the
present study indicate that NHL is associated with 3.0% of
AIDS cases in the WHO European Region. This figure is
also similar to that found in other immunosuppressed groups
not infected with HIV (Fraumeni & Hoover, 1977; Penn,
1986).
Studies based on AIDS surveillance data tend, however, to
substantially underestimate the real proportion of AIDS
patients who develop NHL. The occurrence of NHL is rarely
the presenting disease in a patient with AIDS; most often
NHL is diagnosed after the development of KS or oppor-
tunistic infections or it may even be silent during life (Mys-
kowski et al., 1990). In a series of 43 patients with AIDS-
associated NHL from Memorial Hospital (Lowenthal et al.,
1988), one third presented initially with KS and one third
had an antecedent opportunistic infection. Furthermore, in
seven out of nine patients with primary lymphoma of the
brain the diagnosis was made at autopsy only (Lowenthal et
al., 1988). Clinical evidence suggests that approximately 10%
of patients with AIDS develop NHL during the course of
their disease (Kaplan et al., 1989; Cremer et al., 1990; Mon-
fardini et al., 1990), but for HIV infected patients treated
with long-term antiretroviral therapy such percentage seems
to increase even more, being nearly 45% after 3 years of
treatment (Pluda et al., 1990).
As already reported by Casabona et al. (1991), also in the
present study the proportions of AIDS cases with NHL were
quite comparable in the different areas of Europe. The dis-
crepant figures derived, however, only from countries (i.e.,
Eastern and Southern Europe) where the AIDS epidemic is
still in a very early phase, and/or the accuracy in NHL
diagnoses may be low (Jensen et al., 1990).
In the United States, IVDUs with AIDS had approx-
imately half the probability of presenting with NHL as com-
pared to homosexual or bisexual men (Beral et al., 1991).
Accordingly, in the present study the frequency of NHL was
higher in homosexual or bisexual men and haemophiliacs
than in IVDUs, but such differences were smaller than in the
United States.
It is possible to hypothesise that the different organisation
of the health care system in most European countries, as
compared to the United States, may allow a more
homogenous access to the diagnostic procedures across the
various strata of the population, including IVDUs, thus
reducing artifactual differences. Indeed, the percentages of
AIDS cases with NHL among homosexual or bisexual men
in the United States and Europe were identical (3.4%),
whereas a remarkable excess of NHL among European
IVDUs was seen (2.6% vs 1.6%). An alternative explanation
of this discrepancy between data from Europe and from the
United States may thus be a lower predisposition toward the
development of NHL (or a stronger tendency to develop
opportunistic infections or KS) in North American IVDUs,
who are in a substantial proportion black.
As concerns the proportion of AIDS-associated NHL in
different age groups, the present data from the WHO
European Region and the data from the United States are
consistent in showing a bimodal distribution, with a first
peak in adolescence (i.e. age 10-19) and the second in middle
age (50-59 years). Unfortunately, the information on type of
NHL (i.e., immunoblastic lymphoma, Burkitt's lymphoma
and brain lymphoma) was not available in the present data
set, thus hampering the interpretation of this age-related
behaviour, which is partly different from that recorded in the
age curve of non AIDS-associated NHL (Pickle et al., 1987;
World Health Organization, 1990). According to Beral et al.
(1991), however, the early peak should be attributed to the
early occurrence of Burkitt's lymphoma, while the subse-
quent increase at older age should chiefly reflect the steady
rise of immunoblastic lymphoma with age.
Two potential differences in AIDS-associated NHL accord-
ing to HIV transmission categories (i.e., sexual versus
parenteral transmission) emerged for the first time from the
present study. The frequency of AIDS cases presenting with
NHL seemed to decline over the examined calendar period
and across subsequent age groups in IVDUs, but not in
homosexual or bisexual men and in heterosexuals. The study
of such discrepant patterns is made difficult by the substan-
tial differences in both the geographic and age distribution
between the largest HIV transmission categories. At this
regard, a certain excess of IVDUs in Southern European
countries, more lately involved by the AIDS epidemic than
Northern countries (European Centre for the Epidemio-
logical Monitoring of AIDS, 1991) and the lack of middle
age individuals among IVDUs is worth noting.
The relative increase of NHL as AIDS-indicator disease
among homosexual or bisexual men over the calendar period
and age may mirror the parallel decrease in KS, but other
possible explanations (e.g., differential changes in the fre-
quency of competing indicator diseases other than KS or in
diagnostic accuracy over time and/or age) are also worth
considering.
These differences in the distribution of AIDS-associated
NHL between IVDUs and homosexual or bisexual men must
be interpreted with utmost caution, on account of the
aforementioned limitations of the reporting system. We
think, however, that they deserve further attention and inves-
tigation, possibly by means of datasets which include inform-
ation on the follow up of AIDS patients and the histologic
types of NHL.
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